GO:0050829 defense response to Gram-negative bacterium: Innate Immunity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050829 describes the biological process of reactions triggered by Gram-negative bacteria that protect the cell or organism.
• Recognition of Gram-negative bacteria relies on pattern-recognition receptors detecting lipopolysaccharide (LPS), flagellin, and other microbial ligands.
• Outer membrane vesicles (OMVs) from Gram-negative bacteria can deliver LPS into the host cytosol, activating caspase-11 and non-canonical inflammasome responses.
• Host defense peptides and peptide-mimicking prodrugs are being developed to target multidrug-resistant Gram-negative pathogens.
• Biofilm exopolysaccharides and bacterial membrane vesicles modulate host sensory neurons and immune responses during infection.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of genes in the defense response to Gram-negative bacteria.
Description
The Gene Ontology term GO:0050829, defense response to Gram-negative bacterium, defines the set of reactions triggered in a host cell or organism upon encountering a Gram-negative bacterium, which act to protect the host. Gram-negative bacteria are distinguished by an outer membrane containing lipopolysaccharide (LPS), a potent immunostimulatory molecule that is sensed by innate immune receptors such as Toll-like receptor 4 (TLR4). This process is fundamental to innate immunity and is studied across immunology, microbiology, and infectious disease research. Understanding GO:0050829 is critical because Gram-negative pathogens cause severe infections, including sepsis, pneumonia, and coliform mastitis, and because multidrug-resistant strains are an escalating global health threat. The defense response involves coordinated detection of bacterial components, signal transduction, and effector mechanisms that neutralize or clear the pathogen. Recent research has revealed that Gram-negative bacteria release outer membrane vesicles (OMVs) that can deliver LPS to the host cytosol, triggering caspase-11-dependent responses. Additionally, biofilm exopolysaccharides and bacterial membrane vesicles can alter host sensory-neuron-mediated sickness behaviors during lung infection. These findings highlight the complexity and clinical relevance of the defense response to Gram-negative bacteria.
defense response to Gram-negative bacterium At A Glance
| GO ID | GO:0050829 |
|---|---|
| GO term | defense response to Gram-negative bacterium |
| Ontology | biological_process |
| Synonym | defence response to Gram-negative bacteria; defence response to Gram-negative bacterium; defense response to Gram-negative bacteria; Gram-negative antibacterial peptide activity |
| Major function | Protection of the cell or organism against Gram-negative bacterial infection through detection and effector mechanisms |
| Related processes | Innate immune response, inflammatory response, antimicrobial peptide production, inflammasome activation |
| Key receptors | TLR4, TLR5, NLRP3, caspase-11 (non-canonical inflammasome) |
| Clinical relevance | Sepsis, pneumonia, coliform mastitis, infections by multidrug-resistant Gram-negative pathogens |
What Is GO:0050829?
GO:0050829 is a biological process term defined as reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. It encompasses the detection of Gram-negative bacterial molecules, the activation of signaling cascades, and the execution of antimicrobial effector functions. This term is distinct from general defense response to bacterium (GO:0042742) because it specifically refers to responses directed against Gram-negative bacteria. The process includes both cell-autonomous responses, such as inflammasome activation and antimicrobial peptide production, and organism-level responses, such as immune cell recruitment and inflammation.
Why Is defense response to Gram-negative bacterium Important in Cell Biology?
The defense response to Gram-negative bacteria is a cornerstone of innate immunity and is essential for host survival during infection. Dysregulation of this process can lead to excessive inflammation, tissue damage, or failure to clear pathogens, contributing to diseases such as sepsis and chronic infections. Understanding the molecular players and pathways involved is critical for developing new therapeutics, especially as antibiotic resistance among Gram-negative bacteria rises.
• Gram-negative bacteria cause life-threatening infections including sepsis, pneumonia, and meningitis.
• The defense response is initiated by pattern-recognition receptors such as TLR4 and TLR5 that detect LPS and flagellin.
• Caspase-11 detects cytosolic LPS delivered by outer membrane vesicles, leading to pyroptosis and inflammation.
• Biofilm exopolysaccharides from Gram-negative bacteria can modulate host sensory neurons and sickness behavior.
• Host defense peptides and prodrugs targeting Gram-negative pathogens are promising therapeutic strategies.
• Coliform mastitis in dairy cattle is a major disease caused by Gram-negative bacteria, with significant economic impact.
• Bacteriophage-host interactions offer alternative approaches to combat Gram-negative infections.
• Membrane vesicles released by Gram-negative bacteria in response to host environment are key virulence and signaling vehicles.
• CRISPR-based gene editing enables functional dissection of host genes in this defense process.
• Understanding this process aids in vaccine and therapeutic development against multidrug-resistant pathogens.
What Happens During defense response to Gram-negative bacterium?
Recognition of Gram-negative bacterial components
In simple terms: The host detects molecules unique to Gram-negative bacteria, such as LPS, and alerts the immune system.
The defense response begins with pattern-recognition receptors (PRRs) recognizing conserved microbial structures. TLR4 recognizes lipopolysaccharide (LPS) on the outer membrane of Gram-negative bacteria, while TLR5 detects flagellin. This recognition triggers intracellular signaling cascades that activate transcription factors such as NF-kB and IRFs, leading to the expression of pro-inflammatory cytokines and antimicrobial peptides.
Inflammasome activation and pyroptosis
In simple terms: When LPS enters the host cell cytosol, it activates a protein complex called the inflammasome, which causes a form of inflammatory cell death.
Caspase-11 (in mice) or caspase-4/5 (in humans) directly binds cytosolic LPS, leading to its activation and subsequent cleavage of gasdermin D, which forms pores in the plasma membrane and induces pyroptosis. This process is critical for restricting bacterial replication but can also contribute to septic shock. Outer membrane vesicles (OMVs) released by Gram-negative bacteria facilitate the delivery of LPS into the host cytosol, thereby activating caspase-11.
Production of antimicrobial peptides and effectors
In simple terms: The host produces small proteins that kill bacteria or inhibit their growth.
Upon detection of Gram-negative bacteria, epithelial cells and immune cells secrete antimicrobial peptides such as defensins and cathelicidins, which disrupt bacterial membranes. Additionally, reactive oxygen species (ROS) and nitric oxide (NO) are generated to kill phagocytosed bacteria. The GO synonym 'Gram-negative antibacterial peptide activity' reflects the importance of these peptides in the defense response.
Neural and systemic responses
In simple terms: The host can also respond to infection through the nervous system, leading to sickness behaviors.
Biofilm exopolysaccharides from Gram-negative bacteria can alter sensory-neuron-mediated sickness during lung infection, demonstrating a neuro-immune axis in the defense response. Bacterial membrane vesicles released in response to host environment can also modulate immune responses and contribute to pathogenesis.
Key Genes Involved in GO:0050829 defense response to Gram-negative bacterium
The following genes and proteins are central to the defense response to Gram-negative bacteria, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Recognizes LPS and initiates signaling | Master sensor of Gram-negative bacteria; KO mice are hyporesponsive to LPS |
| TLR5 | Recognizes bacterial flagellin | Mediates detection of motile Gram-negative bacteria |
| CASP4 | Human caspase-4, binds cytosolic LPS | Non-canonical inflammasome activation; KO reduces pyroptosis |
| CASP5 | Human caspase-5, binds cytosolic LPS | Contributes to inflammasome responses |
| CASP11 | Mouse caspase-11, binds cytosolic LPS | Key effector of LPS-induced pyroptosis in mice |
| GSDMD | Gasdermin D, forms membrane pores | Executes pyroptosis downstream of caspases |
| NLRP3 | Inflammasome sensor | Activated by Gram-negative bacterial components |
| MYD88 | Adaptor for TLR signaling | Essential for TLR4 and TLR5 signaling |
| TRIF | Adaptor for TLR4 signaling | Mediates MyD88-independent pathway |
| NFKB1 | Transcription factor | Drives expression of pro-inflammatory genes |
| IL1B | Pro-inflammatory cytokine | Processed by caspase-1 and released during pyroptosis |
| IL18 | Pro-inflammatory cytokine | Released during inflammasome activation |
| DEFB4A | Beta-defensin 4A | Antimicrobial peptide against Gram-negative bacteria |
| CAMP | Cathelicidin antimicrobial peptide | Directly kills Gram-negative bacteria |
| LYZ | Lysozyme | Degrades peptidoglycan of Gram-negative bacteria |
| NOS2 | Inducible nitric oxide synthase | Produces NO to kill bacteria |
| CYBB | NADPH oxidase subunit | Generates ROS for bacterial killing |
| P2RX7 | Purinergic receptor | Activates NLRP3 inflammasome in response to ATP |
How Is defense response to Gram-negative bacterium Regulated?
The defense response to Gram-negative bacteria is tightly regulated at multiple levels. TLR signaling is controlled by negative regulators such as IRAK-M and SOCS proteins to prevent excessive inflammation. Inflammasome activation is regulated by phosphorylation and ubiquitination of caspase-11 and NLRP3. Additionally, host-environment interactions influence the release of bacterial membrane vesicles, which can modulate the immune response. Biofilm exopolysaccharides can alter sensory neuron activity, providing a neuro-immune regulatory layer.
defense response to Gram-negative bacterium and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR4 | Sepsis, endotoxin tolerance | TLR4 knockout mice, macrophage cell lines |
| CASP11 | Septic shock, pyroptosis | Casp11 knockout mice, bone marrow-derived macrophages |
| GSDMD | Inflammatory cell death | Gsdmd knockout mice, human cell lines |
| IL1B | Autoinflammatory diseases | Il1b knockout mice, patient-derived cells |
| NOS2 | Chronic infection, inflammation | Nos2 knockout mice, epithelial cells |
Sepsis and septic shock
Gram-negative bacteria are a leading cause of sepsis, a life-threatening condition characterized by systemic inflammation. Excessive activation of TLR4 and caspase-11 by LPS contributes to cytokine storm and organ failure. Understanding the defense response is critical for developing therapies that modulate inflammation without compromising bacterial clearance.
Coliform mastitis
Coliform mastitis is an inflammation of the mammary gland caused by Gram-negative bacteria such as Escherichia coli. It is a major disease in dairy cattle, leading to reduced milk production and economic losses. The defense response involves TLR4-mediated recognition and neutrophil recruitment.
Multidrug-resistant infections
The rise of multidrug-resistant Gram-negative pathogens, including Pseudomonas aeruginosa and Acinetobacter baumannii, poses a global health threat. Novel antibiotics and host-defense peptide mimetics are being developed to target these pathogens. Understanding host defense mechanisms can inform adjunctive therapies.
Neuro-immune interactions in lung infection
During lung infection with Gram-negative bacteria, biofilm exopolysaccharides can modulate sensory neurons, affecting sickness behavior and immune responses. This highlights the importance of neuro-immune crosstalk in the defense response.
From defense response to Gram-negative bacterium-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate LPS-induced pyroptosis? | Casp11 or Gsdmd knockout macrophages |
| Is TLR4 required for defense against Gram-negative bacteria? | TLR4 knockout mice challenged with E. coli |
| Does a point mutation in CASP4 affect LPS binding? | CRISPR point-mutation knock-in in human monocytes |
| Can overexpression of DEFB4A enhance bacterial killing? | Epithelial cell lines overexpressing DEFB4A |
| What is the role of a candidate gene in sepsis? | Conditional knockout mice in myeloid lineage |
| Does a SNP in NLRP3 alter inflammasome activation? | Knock-in mice carrying the human SNP |
How to Study the defense response to Gram-negative bacterium Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify upregulated defense genes upon infection |
| Proteomics | Protein abundance and modifications | Quantify inflammasome components and cytokines |
| CRISPR knockout screen | Gene essentiality for defense | Discover novel host factors in LPS response |
| Imaging (confocal) | Subcellular localization | Track OMV delivery of LPS to cytosol |
| ELISA | Cytokine secretion | Measure IL-1beta and IL-18 release |
| Flow cytometry | Immune cell activation | Assess pyroptosis and surface markers |
| Western blot | Protein cleavage and activation | Detect caspase-11 and gasdermin D cleavage |
Transcriptomic profiling (RNA-seq)
RNA sequencing can identify global changes in gene expression following exposure to Gram-negative bacteria or LPS. This approach reveals upregulated antimicrobial peptides, cytokines, and inflammasome components.
Proteomics and secretome analysis
Mass spectrometry-based proteomics can quantify proteins released during the defense response, including cytokines and antimicrobial peptides. Secretome analysis identifies effector molecules secreted by infected cells.
Imaging of bacterial-host interactions
Fluorescence microscopy and live-cell imaging can visualize the localization of Gram-negative bacteria, OMVs, and inflammasome components within host cells.
CRISPR screening
Genome-wide CRISPR knockout screens can identify host genes that are essential for defense against Gram-negative bacteria or that mediate LPS-induced cell death.
How CRISPR Can Be Used to Study GO:0050829 defense response to Gram-negative bacterium
Knockout
CRISPR knockout of candidate genes such as TLR4, CASP11, or GSDMD in cell lines or mice enables loss-of-function studies to determine their role in the defense response to Gram-negative bacteria.
Point Mutation
Introducing specific point mutations (e.g., in the LPS-binding domain of caspase-4) via CRISPR base editing or HDR allows precise structure-function analysis of defense proteins.
Knock-in
Knock-in of human orthologs or tagged versions (e.g., GFP-tagged NLRP3) into model organisms or cell lines facilitates tracking and functional studies of defense components.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of antimicrobial peptides (e.g., DEFB4A) can enhance bacterial killing and be used to test therapeutic potential.
How EDITGENE Supports defense response to Gram-negative bacterium Research
Researchers studying defense response to Gram-negative bacterium-related genes often need to determine whether a candidate gene is causally involved in pathogen detection, inflammasome activation, or bacterial clearance. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for defense response to Gram-negative bacterium research.
Frequently Asked Questions About defense response to Gram-negative bacterium
What is GO:0050829 defense response to Gram-negative bacterium?
GO:0050829 is a Gene Ontology biological process term describing reactions triggered by the presence of a Gram-negative bacterium that protect the cell or organism.
What genes are involved in defense response to Gram-negative bacteria?
Key genes include TLR4, TLR5, CASP4, CASP5, CASP11, GSDMD, NLRP3, MYD88, and NFKB1, among others.
How do host cells detect Gram-negative bacteria?
Host cells detect Gram-negative bacteria via pattern-recognition receptors such as TLR4 (recognizing LPS) and TLR5 (recognizing flagellin).
What is the role of caspase-11 in Gram-negative bacterial infection?
Caspase-11 binds cytosolic LPS delivered by outer membrane vesicles, leading to pyroptosis and inflammation.
What diseases are associated with defective defense against Gram-negative bacteria?
Defects can lead to sepsis, severe infections, and poor clearance of pathogens like E. coli and Pseudomonas aeruginosa.
How can CRISPR be used to study defense response to Gram-negative bacteria?
CRISPR knockout, knock-in, and overexpression models allow functional dissection of genes involved in detection and effector mechanisms.
What are outer membrane vesicles (OMVs) and their role in defense?
OMVs are released by Gram-negative bacteria and can deliver LPS to the host cytosol, activating caspase-11.
What is coliform mastitis?
Coliform mastitis is an inflammation of the mammary gland caused by Gram-negative bacteria such as E. coli, common in dairy cattle.
Are there antimicrobial peptides that target Gram-negative bacteria?
Yes, host defense peptides such as defensins and cathelicidins, as well as synthetic mimetics, can kill Gram-negative bacteria.
How does biofilm exopolysaccharide affect the defense response?
Biofilm exopolysaccharides can alter sensory-neuron-mediated sickness behavior during lung infection, modulating the host response.
Conclusion
The defense response to Gram-negative bacteria (GO:0050829) is a vital biological process that integrates pathogen recognition, inflammasome activation, and antimicrobial effector mechanisms. Research using CRISPR models continues to uncover new players and therapeutic targets. EDITGENE offers comprehensive services to support this research.
References
- 1. Akira S et al.. 2006. Pathogen recognition and innate immunity.. Cell 124(4):783-801 PMID: 16497588
- 2. Granton E et al.. 2024. Biofilm exopolysaccharides alter sensory-neuron-mediated sickness during lung infection.. Cell 187(8):1874-1888.e14 PMID: 38518773
- 3. Dicks LMT et al.. 2024. Bacteriophage-Host Interactions and the Therapeutic Potential of Bacteriophages.. Viruses 16(3) PMID: 38543843
- 4. Vanaja SK et al.. 2016. Bacterial Outer Membrane Vesicles Mediate Cytosolic Localization of LPS and Caspase-11 Activation.. Cell 165(5):1106-1119 PMID: 27156449
- 5. Hogan J et al.. 2003. Coliform mastitis.. Vet Res 34(5):507-19 PMID: 14556693
- 6. Wang Z et al.. 2022. A naturally inspired antibiotic to target multidrug-resistant pathogens.. Nature 601(7894):606-611 PMID: 34987225
- 7. Xie J et al.. 2025. A host defense peptide-mimicking prodrug activated by drug-resistant Gram-negative bacterial infections.. Sci Transl Med 17(801):eadl4870 PMID: 40465689
- 8. Volgers C et al.. 2018. Gram-negative bacterial membrane vesicle release in response to the host-environment: different threats, same trick?. Crit Rev Microbiol 44(3):258-273 PMID: 28741415
